Two consecutive successful live birth in woman with 17α hydroxylase deficiency by frozen-thaw embryo transfer under hormone replacement endometrium preparation.
Michio KitajimaKiyonori MiuraTsuneo InoueYuko MurakamiYuriko KitajimaNaoko MurakamiKen TaniguchiKo-Ichiro YoshiuraHideaki MasuzakiPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2017)
17α-Hydroxylase deficiency is rare autosomal recessive disorder that manifested by hypertension, hypokalemia, delayed sexual development, primary amenorrhea and infertility. The information regarding infertility care and conception in women with this disorder are extremely limited. We report a 24-year-old Japanese woman with primary amenorrhea who was diagnosed as partial 17α-hydroxylase deficiency caused by homozygous 3 bp deletion in exon 1 of 17α-hydroxylase gene. In vitro fertilization with controlled ovarian stimulation was carried out and all viable embryo were frozen. During ovarian stimulation, serum progesterone levels were markedly elevated, and endometrial growth was impaired. Utilizing frozen-thaw embryo transfer under hormonal replacement (glucocorticoid, estradiol and progesterone), she had successfully given two consecutive live birth. Women with 17α-hydroxylase deficiency with residual ovarian reserve can afford reproductive success by appropriate diagnosis and treatment by assisted reproductive technology.
Keyphrases
- replacement therapy
- blood pressure
- polycystic ovary syndrome
- estrogen receptor
- healthcare
- palliative care
- mental health
- gene expression
- quality improvement
- pregnancy outcomes
- genome wide
- insulin resistance
- intellectual disability
- skeletal muscle
- pain management
- endometrial cancer
- dna methylation
- transcription factor
- health information
- smoking cessation
- liquid chromatography
- genome wide identification